JANE STREET GROUP, LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 32 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2022$8,123
-75.4%
25,126
-2.1%
0.00%
Q4 2021$33,000
-50.7%
25,658
-39.3%
0.00%
Q2 2021$67,000
-36.8%
42,251
-1.9%
0.00%
Q3 2020$106,000
-64.2%
43,052
-48.3%
0.00%
Q2 2020$296,000
+557.8%
83,321
+337.1%
0.00%
Q1 2020$45,000
+2.3%
19,063
+40.2%
0.00%
Q3 2016$44,00013,6000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2016
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 247,911$1,049,0000.14%
Willow Creek Wealth Management Inc. 17,562$74,0000.04%
WEBSTER BANK, N. A. 50,000$212,0000.03%
Brown Advisory Securities, LLC 28,000$118,0000.02%
Sterling Investment Advisors, Ltd. 2,500$11,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$106,0000.00%
AE Wealth Management LLC 10,000$42,0000.00%
SIMPLEX TRADING, LLC 9,653$40,0000.00%
GROUP ONE TRADING, L.P. 51,397$217,0000.00%
LS Investment Advisors, LLC 3,000$13,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders